A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine
Clinical trial NCT00505453 · COMPLETED
Trial details
- NCT number
- NCT00505453
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.